Quotes 5-day view Delayed Nasdaq
1 043 551
1 062 704
Estimated financial data (e) (USD)
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is focused on developing and commercializing novel cancer therapeutics that reactivate mutant protein 53 (p53) tumor suppressor protein. The Company's lead product candidate, APR-246, or eprenetapopt, is a small molecule p53 reactivator that is in clinical development for hematologic malignancies, including myelodysplastic syndromes, or...
All news about APREA THERAPEUTICS, INC.
07:28a Berenberg Bank Adjusts Aprea Therapeutics' Price Target to $1 From $4, Maintains Hold R..
05/17 APREA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Completion of Acqui..
05/17 APREA THERAPEUTICS, INC.(NASDAQGS : APRE) added to NASDAQ Composite Index
05/16 APREA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a..
05/16 TRANSCRIPT : Aprea Therapeutics, Inc. - Special Call
05/16 APREA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Regulation FD Di..
05/16 Aprea Therapeutics Announces Acquisition of Atrin Pharmaceuticals Inc. and Reports Firs..
05/16 Aprea Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31,..
05/16 APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from NASDAQ Composite Index
05/16 ATRIN PHARMACEUTICALS LLC ACQUIRED A : APRE) in a reverse merger transaction.
03/16 HC Wainwright Adjusts Aprea Therapeutics' Price Target to $2 From $4, Maintains Neutral..
03/16 RBC Trims Price Target on Aprea Therapeutics to $4 From $5, Maintains Sector Perform Ra..
03/15 APREA THERAPEUTICS : Reports Fourth Quarter and Full Year 2021 Financial Results and Provi..
03/15 APREA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a..
03/15 Aprea Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, ..
News in other languages on APREA THERAPEUTICS, INC.
Analyst Recommendations on APREA THERAPEUTICS, INC.
Chart APREA THERAPEUTICS, INC.
Technical analysis trends APREA THERAPEUTICS, INC.
Short Term Mid-Term Long Term Trends Neutral Neutral Neutral